Skip to main content
padlock icon - secure page this page is secure

Intraoperative hyperthermic intraperitoneal chemotherapy after cytoreductive surgery for peritoneal carcinomatosis in an experimental model

The full text article is not available for purchase.

The publisher only permits individual articles to be downloaded by subscribers.

Background:

The combination of cytoreductive surgery (CS) and hyperthermic intraperitoneal chemotherapy (HIPEC) is the treatment of choice for selected patients with peritoneal carcinomatosis (PC) of colorectal origin. However, it remains to be proven whether the addition of HIPEC to CS is essential for the reported survival benefit.

Methods:

Sixty WAG/Rij rats were inoculated intraperitoneally with the rat colonic carcinoma cell line CC‐531. Animals were randomized into three treatment groups: CS alone, CS followed by HIPEC (mitomycin 15 mg/m2) and CS followed by HIPEC (mitomycin 35 mg/m2). Survival was the primary outcome parameter.

Results:

The median survival of rats treated with CS alone was 43 days. Rats receiving HIPEC 15 mg/m2 and HIPEC 35 mg/m2 both had a significantly longer median survival of 75 days (P = 0·003) and 97 days (P < 0·001) respectively. Rats receiving HIPEC showed a significantly lower tumour load at autopsy compared with rats treated with CS alone.

Conclusion:

A combination of CS and HIPEC results in longer survival than CS alone in rats with PC of colorectal origin. Copyright © 2010 British Journal of Surgery Society Ltd. Published by John Wiley & Sons, Ltd.
No References
No Citations
No Supplementary Data
No Article Media
No Metrics

Document Type: Research Article

Publication date: December 1, 2010

More about this publication?
  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content
Cookie Policy
X
Cookie Policy
Ingenta Connect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more